Heron Therapeutics Inc vs Ryanair Holdings plc — how do they compare? Heron Therapeutics Inc trades at $0.48 (market cap $91.46M), while Ryanair Holdings plc trades at $58.99 (market cap $29.31B). The key difference: Ryanair Holdings plc is far larger — about 320.5× Heron Therapeutics Inc's market cap, and Ryanair Holdings plc pays a 1.68% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| HRTX | RYAAY | |
|---|---|---|
Market Cap | $91.46M | $29.31B |
Sector | Health | Industrials |
52-Week High | $1.96 | $73.82 |
52-Week Low | $0.39 | $53.24 |
Enterprise Value | $189.36M | $26.33B |
Dividend Yield | — | 1.68% |
Trailing returns across standard periods
Latest headlines on both assets
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →Ryanair is the leading airline group by passenger numbers in Europe. The company employs a low-cost no-frills model to offer low fares to leisure customers on short-haul intra-European routes. In 2020, the most recent pre-pandemic fiscal year, the company carried 149 million passengers, utilizing a fleet of 467 Boeing 737 aircraft across its 1,800 routes. To keep costs low the company serves predominantly lower-cost secondary airports. The company generated sales of EUR 8.5 billion in fiscal 2020.
Read more on RYAAY →